Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NHMD... Nice churn upwards... :)
Good day going.. :)
Nice day going on with NHMD... :)
Added a few more.. :)
Just a matter of time and NHMD is going to take off... (IMO).. :)
Added a few more.. :)
Added a few more.. :)
Added a few more.. :)
Crazy trading going on today... hmmmmm
Added a few more… :)
Adding…. :)
Added a few more today…. :)
Nice.. Thanks for sharing. $$$... :)
Added a few more.. :)
As always, a voice of reason.
NHMD.. Nice day .. :)
Same here.. All Good.. :)
Added... :)
You bet.. :)
Going to add more.. :)
Had to jump in for a few.. (last week).. :)
Added a few. Good luck to all... :)
Added a few more today.. :)
Nice BDPT day.. (added a few more shares down here)... :)
Flippers flipping.. No Biggie.. :)
Nice bids showing up.. :)
From recent filing..
Remarks:
As of September 18, 2023, Symetryx Corporation does not own any shares of Common Stock of NeuBase Therapeutics, Inc
Flippers dream.. :)
All Good!.. :)
I added a few more… .. :)
Agreed... :)
Flippers paradise... :) (with a touch of investment.. :)
I'm in it to make a profit. (I know you are also).. :)
If I were SYMETRYX Corp, I would proceed to buy more shares… :)
Just saying
Might as well…. :)
NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder
September 08 2023 - 07:00AM
GlobeNewswire Inc.
NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”) today issued the following statement regarding the Schedule 13D filed with the U.S. Securities and Exchange Commission on August 31, 2023, by Symetryx Corporation (“Symetryx”) and their subsequent press release issued on September 6, 2023.
“The NeuBase Board of Directors (“Board”) appreciates input from its shareholders. The Board remains committed to completing its comprehensive exploration of strategic alternatives focused on maximizing shareholder value. The Board does not believe that shareholder value will be enhanced by issuing the special $1 per share dividend Symetryx requested in their press release. The Board and management will continue to seek an open and active dialogue with its shareholders, including Symetryx.”
Been a good stock to play with.. (All Good).. :)
Getting back in.. :)
NBSE.. ROCKING!!!!... :)
Agree… :)